Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
about
Nonalcoholic fatty liver disease as a multi-systemic diseaseEndocrine causes of nonalcoholic fatty liver diseaseNon-invasive separation of alcoholic and non-alcoholic liver disease with predictive modelingAdvanced non-alcoholic steatohepatitis cirrhosis: A high-risk population for pre-liver transplant portal vein thrombosis.Increased risk of portal vein thrombosis in patients with cirrhosis due to nonalcoholic steatohepatitis.A multi-component classifier for nonalcoholic fatty liver disease (NAFLD) based on genomic, proteomic, and phenomic data domains.Interspecies NASH disease activity whole-genome profiling identifies a fibrogenic role of PPARĪ±-regulated dermatopontinEthanol and liver: recent insights into the mechanisms of ethanol-induced fatty liverDetermining the association between adipokine expression in multiple tissues and phenotypic features of non-alcoholic fatty liver disease in obesityPro-Inflammatory Cytokines but Not Endotoxin-Related Parameters Associate with Disease Severity in Patients with NAFLDRole of hemostatic factors in hepatic injury and disease: animal models de-liver.Plasminogen Activator Inhibitor-1 Predicts Quantity of Hepatic Steatosis Independent of Insulin Resistance and Body Weight.Alcoholic, Nonalcoholic, and Toxicant-Associated Steatohepatitis: Mechanistic Similarities and Differences.Role of Fibrin(ogen) in Progression of Liver Disease: Guilt by Association?Non-alcoholic fatty liver disease in obese adults: clinical aspects and current management strategies.Identification of master genes involved in liver key functions through transcriptomics and epigenomics of methyl donor deficiency in rat: relevance to nonalcoholic liver disease.Idiopathic non-cirrhotic portal hypertension: a review.The future of diagnosing NASH - could a simple blood test be the key?Association between plasminogen activator inhibitor-1 and severity of liver injury and cardiovascular risk in children with non-alcoholic fatty liver disease.PAI-1 4G-4G and MTHFR 677TT in non-hepatitis C virus/hepatitis B virus-related liver cirrhosis.Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease.TM5441, a plasminogen activator inhibitor-1 inhibitor, protects against high fat diet-induced non-alcoholic fatty liver disease.Association of Nonalcoholic Fatty Liver Disease and Venous Thromboembolism in Women With Endometrial Cancer.Intrahepatic vascular changes in non-alcoholic fatty liver disease: Potential role of insulin-resistance and endothelial dysfunction.Prothrombotic factors and nonalcoholic fatty liver disease: an additional link to cardiovascular risk?Serum vascular cell adhesion molecule-1 predicts significant liver fibrosis in non-alcoholic fatty liver disease.Hepatic CD36 downregulation parallels steatosis improvement in morbidly obese undergoing bariatric surgery.Plasminogen activator inhibitor-1 is independently associated with non-alcoholic fatty liver disease whereas leptin and adiponectin vary between genders.Adipose Tissue-Derived Plasminogen Activator Inhibitor-1 Function and Regulation.Association Between Cytokines and Liver Histology in Children with Nonalcoholic Fatty Liver Disease.Reply: To PMID 24375485.Inflammatory Biomarkers and Risk of Atherosclerotic Cardiovascular Disease.Increased risk of venous thromboembolism in hospitalized patients with cirrhosis due to non-alcoholic steatohepatitis.A randomized, controlled, crossover pilot study of losartan for pediatric nonalcoholic fatty liver disease.The impact of non-alcoholic fatty liver disease and metabolic syndrome on the progression of coronary artery calcification
P2860
Q26749290-51243A55-DA0A-46EA-A4BC-251DCBC3C0BEQ26780254-3226E4B0-C9C5-4BF0-8FC4-E06D696888E2Q28540257-D81FBD4E-D305-406B-B5A9-A6B0CF5C53E2Q30274723-7380E790-F33B-4AE7-A9C6-0FC36C4BD1E1Q30300233-73F88B1A-E552-4FB3-8669-27A13FA339D5Q31171499-5AD37068-8993-4A91-86E6-578611AD183CQ33877800-607CE6C3-0AFD-4772-A141-D2225F158D97Q34405039-C3F3FF1B-BD31-4172-8F1F-80A4AA6ED34FQ35113836-1B89BE5A-BDC1-48FF-B747-F4E48FCC254FQ36228033-B589F3CB-DB41-4AAE-8033-D3FC794AD8B5Q37387653-1135333C-A9CF-4169-B926-96A5969A5DE0Q37388222-85AD22AB-E31D-4E77-A221-BB3A174EED9BQ37635136-02133CAE-B3FB-4E37-B0B7-325E2903914CQ37681886-42F32962-3934-48A9-89A6-9D5699317134Q38397177-D8737639-A2A3-4A73-9C1A-C1BD43264FE4Q38470686-7277493F-78AF-4E48-831E-40741CEF2CFEQ38508108-5D788F70-E585-4756-A741-E73B6F9475E6Q38634380-6C130656-5C8D-4C1B-9D2E-FCA0B0215A6CQ38808650-8787A3E5-771D-4A70-B5D9-286A75B2F1DBQ40186562-7821C229-7F74-45A6-84E3-670F04B830B4Q40618944-9BF9F60B-A452-41F9-995F-238B246DEF5AQ45751815-E4AA00A0-D3D9-466A-8879-530BE77F60E2Q46494101-F114869C-CF72-47A7-86FD-8EE9ED5C70E2Q46517321-8A541861-5A7B-4B5C-9F73-0BCD8441D75FQ46630941-1BBD76BA-D67C-4F1E-B247-E2D791200EE8Q49098482-9E408EA8-69C5-472A-BDE0-99ECDAD7B5DEQ50616462-44C462F6-3D9C-494E-A34C-18C7433DBC6CQ51123069-CB0A8B8D-B5CB-4DFB-B5E5-09A17AAE6438Q51361802-93161DD6-960B-4ACD-BC82-44C4A201E860Q52791086-FB77F312-64CB-4E04-8B57-0635AAC2957CQ53716936-0A44773C-08A4-4823-BA32-BBB7F571EA4DQ54942348-933AF7AF-6746-4675-947E-D71EE39268E6Q55342502-93851C50-3D1A-41A4-8A07-218BE6D62732Q55491214-461ABB07-DE33-44FB-A06B-76E53194DD09Q58786857-9002B27E-624C-46DC-B426-E1098011864F
P2860
Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
description
2013 nĆ® lÅ«n-bĆ»n
@nan
2013幓ć®č«ę
@ja
2013幓å¦ęÆęē«
@wuu
2013幓å¦ęÆęē«
@zh-cn
2013幓å¦ęÆęē«
@zh-hans
2013幓å¦ęÆęē«
@zh-my
2013幓å¦ęÆęē«
@zh-sg
2013幓åøč”ęē«
@yue
2013幓åøč”ęē«
@zh
2013幓åøč”ęē«
@zh-hant
name
Prothrombotic factors in histo ...... nonalcoholic steatohepatitis.
@en
Prothrombotic factors in histo ...... nonalcoholic steatohepatitis.
@nl
type
label
Prothrombotic factors in histo ...... nonalcoholic steatohepatitis.
@en
Prothrombotic factors in histo ...... nonalcoholic steatohepatitis.
@nl
prefLabel
Prothrombotic factors in histo ...... nonalcoholic steatohepatitis.
@en
Prothrombotic factors in histo ...... nonalcoholic steatohepatitis.
@nl
P2093
P2860
P50
P356
P1433
P1476
Prothrombotic factors in histo ...... nonalcoholic steatohepatitis.
@en
P2093
An Verrijken
Eric Van Marck
Ilse Mertens
Janne Prawitt
Luc Van Gaal
Sandrine Caron
Sven Francque
P2860
P304
P356
10.1002/HEP.26510
P407
P577
2013-11-08T00:00:00Z